Annual CFO
-$26.26 M
+$10.72 M+28.98%
01 July 2024
Summary:
Enzo Biochem annual cash flow from operations is currently -$26.26 million, with the most recent change of +$10.72 million (+28.98%) on 01 July 2024. During the last 3 years, it has fallen by -$26.65 million (-6885.27%). ENZ annual CFO is now -149.43% below its all-time high of $53.13 million, reached on 31 July 2016.ENZ Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$1.08 M
+$1.78 M+62.09%
01 July 2024
Summary:
Enzo Biochem quarterly cash flow from operations is currently -$1.08 million, with the most recent change of +$1.78 million (+62.09%) on 01 July 2024. Over the past year, it has increased by +$12.29 million (+91.89%). ENZ quarterly CFO is now -103.00% below its all-time high of $36.12 million, reached on 31 July 2016.ENZ Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$26.26 M
+$15.95 M+37.78%
01 July 2024
Summary:
Enzo Biochem TTM cash flow from operations is currently -$26.26 million, with the most recent change of +$15.95 million (+37.78%) on 01 July 2024. Over the past year, it has increased by +$15.40 million (+36.96%). ENZ TTM CFO is now -149.43% below its all-time high of $53.13 million, reached on 31 July 2016.ENZ TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENZ Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.0% | +91.9% | +37.0% |
| 3 y3 years | -6885.3% | +82.0% | -490.4% |
| 5 y5 years | -646.4% | +47.5% | -393.6% |
ENZ Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6885.3% | +29.0% | -72.2% | +93.6% | -516.7% | +40.9% |
| 5 y | 5 years | -646.4% | +29.0% | -147.0% | +93.6% | -326.6% | +40.9% |
| alltime | all time | -149.4% | +29.0% | -103.0% | +93.6% | -149.4% | +40.9% |
Enzo Biochem Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | -$26.26 M(-29.0%) | -$1.08 M(-62.1%) | -$26.26 M(-37.8%) |
| Apr 2024 | - | -$2.86 M(-68.0%) | -$42.20 M(-4.9%) |
| Jan 2024 | - | -$8.94 M(-33.2%) | -$44.40 M(+6.6%) |
| Oct 2023 | - | -$13.37 M(-21.5%) | -$41.66 M(+12.7%) |
| July 2023 | -$36.98 M(+122.9%) | -$17.03 M(+237.0%) | -$36.98 M(+27.4%) |
| Apr 2023 | - | -$5.05 M(-18.5%) | -$29.02 M(+17.0%) |
| Jan 2023 | - | -$6.20 M(-28.7%) | -$24.81 M(+28.9%) |
| Oct 2022 | - | -$8.69 M(-4.2%) | -$19.24 M(+16.0%) |
| July 2022 | -$16.59 M(-4386.8%) | -$9.07 M(+970.8%) | -$16.59 M(+123.8%) |
| Apr 2022 | - | -$847.00 K(+34.4%) | -$7.41 M(+74.1%) |
| Jan 2022 | - | -$630.00 K(-89.6%) | -$4.26 M(-4.3%) |
| Oct 2021 | - | -$6.04 M(-5695.4%) | -$4.45 M(-1249.4%) |
| July 2021 | $387.00 K(-102.3%) | $108.00 K(-95.3%) | $387.00 K(-108.1%) |
| Apr 2021 | - | $2.31 M(-381.3%) | -$4.78 M(-57.4%) |
| Jan 2021 | - | -$820.00 K(-32.1%) | -$11.22 M(-31.3%) |
| Oct 2020 | - | -$1.21 M(-76.1%) | -$16.32 M(-5.0%) |
| July 2020 | -$17.18 M(-457.4%) | -$5.06 M(+22.6%) | -$17.18 M(+12.3%) |
| Apr 2020 | - | -$4.13 M(-30.3%) | -$15.29 M(-231.9%) |
| Jan 2020 | - | -$5.92 M(+186.8%) | $11.59 M(+29.6%) |
| Oct 2019 | - | -$2.07 M(-34.9%) | $8.94 M(+86.1%) |
| July 2019 | $4.81 M(-275.7%) | -$3.17 M(-114.0%) | $4.81 M(-16.0%) |
| Apr 2019 | - | $22.76 M(-365.5%) | $5.72 M(-131.2%) |
| Jan 2019 | - | -$8.57 M(+38.2%) | -$18.34 M(+59.1%) |
| Oct 2018 | - | -$6.20 M(+174.5%) | -$11.53 M(+321.7%) |
| July 2018 | -$2.73 M(+1234.1%) | -$2.26 M(+72.5%) | -$2.73 M(-325.3%) |
| Apr 2018 | - | -$1.31 M(-25.6%) | $1.21 M(-64.9%) |
| Jan 2018 | - | -$1.76 M(-167.8%) | $3.46 M(+27.1%) |
| Oct 2017 | - | $2.60 M(+53.6%) | $2.72 M(-1428.3%) |
| July 2017 | -$205.00 K(-100.4%) | $1.69 M(+80.1%) | -$205.00 K(-100.6%) |
| Apr 2017 | - | $938.00 K(-137.5%) | $34.23 M(+13.2%) |
| Jan 2017 | - | -$2.50 M(+650.5%) | $30.23 M(-23.7%) |
| Oct 2016 | - | -$333.00 K(-100.9%) | $39.64 M(-25.4%) |
| July 2016 | $53.13 M(-1535.8%) | $36.12 M(-1280.5%) | $53.13 M(+147.4%) |
| Apr 2016 | - | -$3.06 M(-144.3%) | $21.47 M(-6.0%) |
| Jan 2016 | - | $6.91 M(-47.5%) | $22.84 M(+87.1%) |
| Oct 2015 | - | $13.15 M(+194.3%) | $12.21 M(-429.9%) |
| July 2015 | -$3.70 M(+118.0%) | $4.47 M(-363.3%) | -$3.70 M(-48.1%) |
| Apr 2015 | - | -$1.70 M(-54.3%) | -$7.13 M(+105.9%) |
| Jan 2015 | - | -$3.72 M(+34.9%) | -$3.46 M(+202.9%) |
| Oct 2014 | - | -$2.75 M(-365.7%) | -$1.14 M(-32.6%) |
| July 2014 | -$1.70 M(-83.1%) | $1.04 M(-47.4%) | -$1.70 M(-59.9%) |
| Apr 2014 | - | $1.97 M(-241.1%) | -$4.23 M(-58.3%) |
| Jan 2014 | - | -$1.40 M(-57.8%) | -$10.15 M(-14.3%) |
| Oct 2013 | - | -$3.31 M(+120.5%) | -$11.85 M(+18.3%) |
| July 2013 | -$10.02 M(+67.7%) | -$1.50 M(-62.0%) | -$10.02 M(+23.8%) |
| Apr 2013 | - | -$3.94 M(+27.4%) | -$8.09 M(+15.7%) |
| Jan 2013 | - | -$3.10 M(+109.6%) | -$6.99 M(+35.8%) |
| Oct 2012 | - | -$1.48 M(-448.3%) | -$5.15 M(-13.8%) |
| July 2012 | -$5.97 M(-28.3%) | $424.00 K(-114.9%) | -$5.97 M(-37.5%) |
| Apr 2012 | - | -$2.84 M(+127.3%) | -$9.56 M(-1.5%) |
| Jan 2012 | - | -$1.25 M(-45.7%) | -$9.70 M(+9.6%) |
| Oct 2011 | - | -$2.30 M(-27.2%) | -$8.85 M(+6.3%) |
| July 2011 | -$8.33 M(-38.2%) | -$3.16 M(+5.8%) | -$8.33 M(+54.5%) |
| Apr 2011 | - | -$2.99 M(+650.5%) | -$5.39 M(-54.7%) |
| Jan 2011 | - | -$398.00 K(-77.7%) | -$11.91 M(-3.9%) |
| Oct 2010 | - | -$1.78 M(+698.7%) | -$12.40 M(-7.9%) |
| July 2010 | -$13.46 M(+17.3%) | -$223.00 K(-97.7%) | -$13.46 M(-15.7%) |
| Apr 2010 | - | -$9.51 M(+971.7%) | -$15.98 M(+44.7%) |
| Jan 2010 | - | -$887.00 K(-68.9%) | -$11.05 M(-13.9%) |
| Oct 2009 | - | -$2.85 M(+3.9%) | -$12.83 M(+11.8%) |
| July 2009 | -$11.48 M(+34.0%) | -$2.74 M(-40.1%) | -$11.48 M(+11.3%) |
| Apr 2009 | - | -$4.57 M(+71.3%) | -$10.32 M(+47.0%) |
| Jan 2009 | - | -$2.67 M(+78.5%) | -$7.02 M(-21.0%) |
| Oct 2008 | - | -$1.50 M(-5.3%) | -$8.89 M(+3.8%) |
| July 2008 | -$8.56 M(+127.4%) | -$1.58 M(+23.7%) | -$8.56 M(+78.5%) |
| Apr 2008 | - | -$1.28 M(-71.9%) | -$4.80 M(-38.0%) |
| Jan 2008 | - | -$4.54 M(+287.5%) | -$7.74 M(+6.4%) |
| Oct 2007 | - | -$1.17 M(-153.5%) | -$7.28 M(+93.2%) |
| July 2007 | -$3.77 M | $2.19 M(-151.8%) | -$3.77 M(-59.4%) |
| Apr 2007 | - | -$4.22 M(+3.7%) | -$9.27 M(+68.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2007 | - | -$4.07 M(-274.0%) | -$5.52 M(-3.1%) |
| Oct 2006 | - | $2.34 M(-170.5%) | -$5.70 M(-44.0%) |
| July 2006 | -$10.18 M(-177.6%) | -$3.32 M(+606.4%) | -$10.18 M(+254.2%) |
| Apr 2006 | - | -$470.00 K(-88.9%) | -$2.87 M(-20.5%) |
| Jan 2006 | - | -$4.25 M(+98.4%) | -$3.62 M(-19.6%) |
| Oct 2005 | - | -$2.14 M(-153.7%) | -$4.50 M(-134.3%) |
| July 2005 | $13.12 M(-335.0%) | $3.98 M(-428.4%) | $13.12 M(+112.9%) |
| Apr 2005 | - | -$1.21 M(-76.3%) | $6.16 M(-22.6%) |
| Jan 2005 | - | -$5.13 M(-133.1%) | $7.96 M(-16.7%) |
| Oct 2004 | - | $15.48 M(-620.4%) | $9.56 M(-271.2%) |
| July 2004 | -$5.58 M(-146.1%) | -$2.97 M(-610.1%) | -$5.58 M(+64.1%) |
| Apr 2004 | - | $583.00 K(-116.5%) | -$3.40 M(+719.4%) |
| Jan 2004 | - | -$3.53 M(-1146.9%) | -$415.20 K(-106.8%) |
| Oct 2003 | - | $337.00 K(-142.4%) | $6.09 M(-49.7%) |
| July 2003 | $12.11 M(+26.7%) | -$794.20 K(-122.2%) | $12.11 M(-28.2%) |
| Apr 2003 | - | $3.57 M(+20.0%) | $16.86 M(+11.4%) |
| Jan 2003 | - | $2.98 M(-53.2%) | $15.13 M(+15.1%) |
| Oct 2002 | - | $6.35 M(+60.6%) | $13.15 M(+37.5%) |
| July 2002 | $9.56 M(+19.5%) | $3.96 M(+114.3%) | $9.56 M(+20.0%) |
| Apr 2002 | - | $1.85 M(+86.5%) | $7.96 M(-4.7%) |
| Jan 2002 | - | $990.00 K(-64.2%) | $8.36 M(+1.2%) |
| Oct 2001 | - | $2.77 M(+17.1%) | $8.26 M(+3.3%) |
| July 2001 | $8.00 M(+62.2%) | $2.36 M(+5.3%) | $8.00 M(-11.6%) |
| Apr 2001 | - | $2.24 M(+152.6%) | $9.05 M(+23.5%) |
| Jan 2001 | - | $888.00 K(-64.5%) | $7.32 M(+4.1%) |
| Oct 2000 | - | $2.50 M(-26.6%) | $7.04 M(+42.7%) |
| July 2000 | $4.93 M(-55.6%) | $3.41 M(+554.6%) | $4.93 M(+44.2%) |
| Apr 2000 | - | $521.00 K(-13.2%) | $3.42 M(-30.2%) |
| Jan 2000 | - | $600.00 K(+50.0%) | $4.90 M(-9.3%) |
| Oct 1999 | - | $400.00 K(-78.9%) | $5.40 M(-51.4%) |
| July 1999 | $11.10 M(+33.7%) | $1.90 M(-5.0%) | $11.10 M(+8.8%) |
| Apr 1999 | - | $2.00 M(+81.8%) | $10.20 M(+8.5%) |
| Jan 1999 | - | $1.10 M(-82.0%) | $9.40 M(-1.1%) |
| Oct 1998 | - | $6.10 M(+510.0%) | $9.50 M(+14.5%) |
| July 1998 | $8.30 M(+7.8%) | $1.00 M(-16.7%) | $8.30 M(-6.7%) |
| Apr 1998 | - | $1.20 M(0.0%) | $8.90 M(+8.5%) |
| Jan 1998 | - | $1.20 M(-75.5%) | $8.20 M(+20.6%) |
| Oct 1997 | - | $4.90 M(+206.3%) | $6.80 M(-11.7%) |
| July 1997 | $7.70 M(+26.2%) | $1.60 M(+220.0%) | $7.70 M(-2.5%) |
| Apr 1997 | - | $500.00 K(-350.0%) | $7.90 M(+9.7%) |
| Jan 1997 | - | -$200.00 K(-103.4%) | $7.20 M(-5.3%) |
| Oct 1996 | - | $5.80 M(+222.2%) | $7.60 M(+24.6%) |
| July 1996 | $6.10 M(-33.0%) | $1.80 M(-1000.0%) | $6.10 M(+64.9%) |
| Apr 1996 | - | -$200.00 K(-200.0%) | $3.70 M(+42.3%) |
| Jan 1996 | - | $200.00 K(-95.3%) | $2.60 M(-750.0%) |
| Oct 1995 | - | $4.30 M(-816.7%) | -$400.00 K(-104.4%) |
| July 1995 | $9.10 M(-384.4%) | -$600.00 K(-53.8%) | $9.10 M(-1.1%) |
| Apr 1995 | - | -$1.30 M(-53.6%) | $9.20 M(-1.1%) |
| Jan 1995 | - | -$2.80 M(-120.3%) | $9.30 M(-19.1%) |
| Oct 1994 | - | $13.80 M(-2860.0%) | $11.50 M(-459.4%) |
| July 1994 | -$3.20 M(-500.0%) | -$500.00 K(-58.3%) | -$3.20 M(+18.5%) |
| Apr 1994 | - | -$1.20 M(+100.0%) | -$2.70 M(+125.0%) |
| Jan 1994 | - | -$600.00 K(-33.3%) | -$1.20 M(+300.0%) |
| Oct 1993 | - | -$900.00 K(<-9900.0%) | -$300.00 K(-137.5%) |
| July 1993 | $800.00 K(-61.9%) | $0.00(-100.0%) | $800.00 K(-63.6%) |
| Apr 1993 | - | $300.00 K(0.0%) | $2.20 M(-8.3%) |
| Jan 1993 | - | $300.00 K(+50.0%) | $2.40 M(+4.3%) |
| Oct 1992 | - | $200.00 K(-85.7%) | $2.30 M(+9.5%) |
| July 1992 | $2.10 M(-191.3%) | $1.40 M(+180.0%) | $2.10 M(+61.5%) |
| Apr 1992 | - | $500.00 K(+150.0%) | $1.30 M(+160.0%) |
| Jan 1992 | - | $200.00 K(>+9900.0%) | $500.00 K(-183.3%) |
| Oct 1991 | - | $0.00(-100.0%) | -$600.00 K(-73.9%) |
| July 1991 | -$2.30 M(-54.9%) | $600.00 K(-300.0%) | -$2.30 M(-37.8%) |
| Apr 1991 | - | -$300.00 K(-66.7%) | -$3.70 M(-28.8%) |
| Jan 1991 | - | -$900.00 K(-47.1%) | -$5.20 M(0.0%) |
| Oct 1990 | - | -$1.70 M(+112.5%) | -$5.20 M(+2.0%) |
| July 1990 | -$5.10 M(+8.5%) | -$800.00 K(-55.6%) | -$5.10 M(+18.6%) |
| Apr 1990 | - | -$1.80 M(+100.0%) | -$4.30 M(+72.0%) |
| Jan 1990 | - | -$900.00 K(-43.8%) | -$2.50 M(+56.3%) |
| Oct 1989 | - | -$1.60 M | -$1.60 M |
| July 1989 | -$4.70 M | - | - |
FAQ
- What is Enzo Biochem annual cash flow from operations?
- What is the all time high annual CFO for Enzo Biochem?
- What is Enzo Biochem annual CFO year-on-year change?
- What is Enzo Biochem quarterly cash flow from operations?
- What is the all time high quarterly CFO for Enzo Biochem?
- What is Enzo Biochem quarterly CFO year-on-year change?
- What is Enzo Biochem TTM cash flow from operations?
- What is the all time high TTM CFO for Enzo Biochem?
- What is Enzo Biochem TTM CFO year-on-year change?
What is Enzo Biochem annual cash flow from operations?
The current annual CFO of ENZ is -$26.26 M
What is the all time high annual CFO for Enzo Biochem?
Enzo Biochem all-time high annual cash flow from operations is $53.13 M
What is Enzo Biochem annual CFO year-on-year change?
Over the past year, ENZ annual cash flow from operations has changed by +$10.72 M (+28.98%)
What is Enzo Biochem quarterly cash flow from operations?
The current quarterly CFO of ENZ is -$1.08 M
What is the all time high quarterly CFO for Enzo Biochem?
Enzo Biochem all-time high quarterly cash flow from operations is $36.12 M
What is Enzo Biochem quarterly CFO year-on-year change?
Over the past year, ENZ quarterly cash flow from operations has changed by +$12.29 M (+91.89%)
What is Enzo Biochem TTM cash flow from operations?
The current TTM CFO of ENZ is -$26.26 M
What is the all time high TTM CFO for Enzo Biochem?
Enzo Biochem all-time high TTM cash flow from operations is $53.13 M
What is Enzo Biochem TTM CFO year-on-year change?
Over the past year, ENZ TTM cash flow from operations has changed by +$15.40 M (+36.96%)